Panel: Patient Activation through Digital Consumer Health
Vice President, Partnerships and Strategy
Ashlee leads strategic partnerships for Rock Health and helps develop research that educates portfolio companies, partners, and the digital health community. Prior to joining Rock Health, Ashlee developed The Food Business School's Mentor Network, an online platform to connect entrepreneurs with accomplished food and technology business leaders. Her past work also includes leading Business Development and Product Marketing at Better, a digital health service developed in collaboration with Mayo Clinic. Ashlee received her MBA from the Haas School of Business, where she focused on technology and public health.
Executive Director of Brigham’s Innovation Hub and Director of Strategy and Innovation in the Brigham Research Institute
Lesley Solomon is Executive Director of Brigham’s Innovation Hub and Director of Strategy and Innovation in the Brigham Research Institute. In these roles Lesley is leading Brigham and Women’s Hospital’s effort to foster innovation, collaboration and translation of technology. Lesley and her iHub team work with scientists, clinicians and hospital administrators to solve hospital challenges through digital health. She develops and nurtures relationships with innovative organizations in Boston and beyond identifying collaboration opportunities for co-development, piloting or creating new technologies.
Lesley has 20+ years of experience as an executive doing work in business development, strategy and marketing at startups, early stage, and large companies such as the Food Network, Barnes & Noble.com, and Yoga Works. Lesley received her MBA from Harvard Business School and has a B.A. in English from Cornell University.
Lesley is a co-Founder of the Food Allergy Science Initiative at The Broad Institute and is a board member at Primary Care Progress.
Dr. Rajni Aneja
MD MBA CPE
Global Head, Digital Strategy/Transformation at Novartis
Dr. Rajni Aneja is Global Head, Digital Strategy/Transformation at Novartis. She is a Connection Science Fellow, health care strategist, public speaker, transformative change agent with expertise in population health management and digital health. She serves as an advisor to variety of health and wellness organizations. Dr. Aneja encompasses various vantage points as a clinician, executive, advisor, entrepreneur, speaker and technology advocate serving in senior leadership roles like chief medical officer for WebMD health, EVP of Joslin and strategic executive, transformation leader at Humana. Dr. Aneja is spreading the vision for strategy and innovation across different spectrums of health care. Dr. Aneja received her MD from Research Medical Center in Kansas City and MBA from University of Massachusetts.
Partner, Health and Life Sciences Division at Oliver Wyman
Sukanya Soderland is a Partner in the Health & Life Sciences Practice of Oliver Wyman’s Boston office. She advises health payer and healthcare services clients on developing growth and cost management strategies that help them create a sustainable competitive advantage as the market becomes more consumer-driven and moves towards value based care. She serves as a leader in Oliver Wyman's Health Innovation Center, and she speaks and writes about driving health innovation in a variety of forums, including the Harvard Business Review.
Sukanya’s recent experience includes the following:
- Developed a next generation enterprise-wide integrated population health management strategy and implementation plan for a national payer that identified 5% savings in medical benefit expense
- For a regional Blues plan, developed plan to increase efficiency, effectiveness and member engagement levels for its care management programs and identified $13 M of in-year net savings
- Developed a consumer-centric strategy for a regional health plan’s Board. Work included development of over 100 consumer-facing solutions to address health and lifestyle related hassles and needs of consumers as uncovered by analysis of a 1,700 respondent consumer survey and five focus groups. Profiled and analyzed top ten ideas to redefine the health plan’s strategy, business model and economics and consumer engagement.
- Crafted a private exchange vision for the leadership of a diversified health services company
- Created a post-reform national product strategy and consumer segment valuation approach for a national payer
- For a Blue Cross Blue Shield plan, developed a range of product design strategies to reduce costs, manage excise tax concerns and improve member health and productivity for a select set of large group customers.
- For a large multi-billion dollar grocer and pharmacy chain, developed a strategy to enter into health services provision and create a new multi-billion dollar business
- Developed an extensive front office redesign and transformation effort for a multi-billion dollar health services firm to facilitate a shift from a transactional product focus to a customer- centric, relationship-driven, integrated solutions focus
- Created a long-term health care strategy targeting the Baby Boomer generation for a large affinity organization. Work included extensive market and healthcare product assessments, interviews, development and assessment of alternative business model options and recommendations to the Board
- Established an extensive growth strategy and state-specific implementation plan for a large national specialty provider in the orthotics and prosthetics market
- Quantified the value a large affinity organization had offered to a leading health insurance company over a joint multi-year contract. Identified $10B+ of value through an extensive 1,200 respondent conjoint consumer survey to quantify the impact of the brand, a risk based capital analysis on the structure of the contract, SG&A and other financial analyses
- Co-developed Oliver Wyman’s perspective on Health Market 2.0, population health management, breakthrough consumer engagement and health product of the future through the Oliver Wyman Health Innovation Center
Sukanya has an A.B. (magna cum laude) from Harvard College in Sociology and Economics and an MBA from the Harvard Business School.
Adam Hanina is co-founder and CEO of AiCure, a venture and NIH-funded company that has developed artificial intelligence to confirm medication ingestion by clinical trial participants and high-risk patients in real time. Mr. Hanina has been responsible for much of the vision and strategy at AiCure and is the primary inventor of over 20 patents. He is a passionate advocate for the use of healthcare software as a population health tool and has directed much of his previous work to this end. Prior to AiCure, Mr. Hanina contributed to the development of Cerner Corporation’s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. He has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH). He holds an MBA from the Wharton School of Business.